Avista Public Acquisition Corp. II AHPA
Set alert
6.13 0.00 0.00%
At close
5.83 Day range 7.20
5.83 52-week range 10.50
- Open
- 7.20
- Prev close
- 6.13
- Mkt cap
- 176.09M
- Vol
- 64.53K
- Avg vol
- 67.04K
- EPS
- -0.244
- P/E
- -25.10
- Div yield
- 0.00%
More statistics
- Low
- 5.83
- High
- 7.20
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 1.01
- Inst. own
- 96.95%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.88
- 200-d avg
- 10.01
- 1y target
- 0.00
Key statistics
- Market cap
- 176.09M
- Enterprise value
- 176.68M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.244
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 159.19K
- Total debt
- 750.00K
- Return on equity
- 0.00%
- Shares outstanding
- 23.00M
- Short % of float
- 0.00%
- 50-day average
- 9.88
- 200-day average
- 10.01
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Avista Public Acquisition Corp. II
Avista Public Acquisition Corp. II does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company focuses on pursuing businesses in the healthcare industry. Avista Public Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
News
- OmniAb Announces Completion of Spin-Off and Business Combination
- Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
- OmniAb Business Combination Approved by APAC Shareholders
- Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
- Ligand Reports Second Quarter 2022 Financial Results
- Stocks Which Set New 52-Week High Yesterday, September 11th
Your note
Sign in to keep a note on AHPA — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 6.74% | 1,549,998 | 9.49M | Jun 29, 2022 |
| Marshall Wace LLP | 4.79% | 1,101,548 | 6.75M | Jun 29, 2022 |
| Governors Lane LP | 4.35% | 1,000,000 | 6.13M | Jun 29, 2022 |
| Hudson Bay Capital Management Lp | 4.24% | 974,999 | 5.97M | Jun 29, 2022 |
| BlueCrest Capital Management Ltd | 4.09% | 940,514 | 5.76M | Jun 29, 2022 |
| MMCAP International, Inc. SPC | 4.02% | 924,999 | 5.67M | Jun 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | 1.99% | 458,199 | 2.81M | Jun 29, 2022 |
| Merger Fund, The | 1.88% | 431,754 | 2.64M | Jun 29, 2022 |
| First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd | 0.15% | 35,419 | 216.94K | Jun 29, 2022 |
| JNL Series Trust-JNL/Multi Manager Alternative Fund | 0.09% | 20,110 | 123.17K | Jun 29, 2022 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 6,982 | 42.76K | Aug 30, 2022 |
| Merger Fund Vl, The | 0.02% | 5,451 | 33.39K | Jun 29, 2022 |